Analyst Ratings for Alterity Therapeutics (ATHE)

ATHE Rating Summary

ATHE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ATHE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $14.00 (+209.7%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/11/2026 Craig-Hallum Adam Vogel New Coverage Buy
(N/A)
12.00
(N/A)
83.33
(4.52)
-94.58% Details
6/29/2026 Jones Trading Debanjana Chatterjee New Coverage Buy
(N/A)
16.00
(N/A)
4.82
(4.52)
-6.22% Details